Skip to main content
    M

    Mineralys Therapeutics, Inc. Common Stock (MLYS)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $14.48
    -0.05 (-0.34%)

    Market Cap: $1.29B

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Mineralys Therapeutics, Inc. Common Stock (MLYS) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Mineralys Therapeutics, Inc. Common Stock (MLYS) has a latest price of $14.48 on Nov 17, 2026, 67.8% below its 52-week high of $44.99. Its price fell 64.6% over the past 12 months. The month-end price rose 135.2% over the 3 years through Oct 2026, a compound annual rate of 33.0%.

    Price Chart

    From Feb 2023 to Oct 2026, its highest month-end close was $43.12 in Nov 2025 and its lowest $6.66 in Nov 2023, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart MLYS with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for MLYS.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 46.3%, and over 6 months it fell 44.4%.

    PeriodChange
    1 month-30.8%
    3 months-46.3%
    6 months-44.4%
    12 months-64.6%
    12 months, with dividends-64.6%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+135.2%+33.0%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2025, when the price rose 194.8%, and its weakest was 2024, when it rose 43.1%.

    YearCloseChange
    2026 through Oct 2026$18.18-49.9%
    2025$36.29+194.8%
    2024$12.31+43.1%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 34.3% below its 50-day average of $22.05 and 44.3% below its 200-day average of $25.99.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$14.48
    52-week high$44.99-67.8%
    52-week low$14.45+0.2%
    50-day average$22.05-34.3%
    200-day average$25.99-44.3%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 69.4%.

    MeasureValue
    1-year beta1.62
    Largest fall, 1 year-67.3%
    Largest fall, 3 years-69.4%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About MLYS

    What is MLYS's 1-year price change?

    Mineralys Therapeutics, Inc. Common Stock's price fell 64.6% over the past 12 months. With dividends included, the 12-month total return was -64.6%.

    How has MLYS stock done over the long term?

    Mineralys Therapeutics, Inc. Common Stock's month-end price rose 135.2% over the 3 years through Oct 2026, a compound annual rate of 33.0%. These figures leave out dividends.

    What is MLYS's 52-week high and low?

    Mineralys Therapeutics, Inc. Common Stock's 52-week high is $44.99 and its 52-week low is $14.45. Its latest price of $14.48 on Nov 17, 2026 is 67.8% below the high.

    What is MLYS's beta?

    Mineralys Therapeutics, Inc. Common Stock's 1-year beta against the S&P 500 is 1.62, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 67.3%.

    Is the MLYS chart free?

    Yes. Advanced Charting for MLYS is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.